OncoSentia™
Minimal Residual Disease

Molecular insights to guide clinical decisions

Driving the implementation of genetics in routine healthcare

Making genetics innovation accessible and actionable in everyday healthcare

Placing genetics at the core of healthcare decisions

Bringing specialised genetic testing into clinical pathways to support informed patient care

Launch and scale genomic capabilities in your laboratory

Validated solutions and practical expertise for confident laboratory implementation
27+ years of genetic testing expertise, with a broad
portfolio of IVDR-certified assays
Solutions validated
in our own accredited
laboratory network before deployment
Translational innovation transforming R&D into
clinically relevant genomic solutions
CAP-, CLIA- and ISO-
accredited laboratories
support quality, precision and efficient delivery

From innovation to implementation

Medicover Genetics enables the implementation of genetics in routine healthcare through an integrated model of specialised clinical services and laboratory solutions. With more than 27 years of clinical genetics experience, the company supports healthcare systems, laboratories, and clinicians worldwide through innovative and translational genetic solutions across oncology, reproductive health, rare diseases, and precision medicine. Operating through CAP, CLIA and ISO 15189 accredited laboratories, Medicover Genetics delivers clinically validated solutions that focus on caring for patients at every stage of their clinical pathway.

Diagnostic solutions

Broad portfolio of genetic testing services designed to integrate genetics into clinical pathways and support informed decisions for patient care, from prevention and lifestyle optimisation to diagnosis, clinical management and monitoring.

Solutions for laboratories

Scalable solutions combining IVDR-certified assays, technologies, workflows, bioinformatics and expertise validated across our accredited network, helping laboratories implement NGS-based testing services with confidence and ease.

Partner with us

Collaborative models spanning clinical trials, evidence generation, validation and implementation, working with universities, laboratories, healthcare organisations and technology providers to advance the field of genomics.

  • OncoSentia MRD

    Tumour-agnostic, plasma-informed liquid biopsy assay to detect and longitudinally monitor circulating tumour DNA (ctDNA) in patients with stage III unresectable NSCLC, enabling molecular assessment during and after treatment, complementing established clinical and radiological monitoring.

  • VERACITY

    New-generation non-invasive prenatal screening from week 9 of pregnancy, analysing fetal cell-free DNA in maternal blood to detect selected chromosomal abnormalities with high sensitivity and specificity for early and reliable prenatal risk assessment.

  • Pharmacogenomics

    Enabling personalised treatments for safer, more effective care through genetic insights that guide optimal prescribing from the start and refine therapy when patients experience side effects or poor response.

  • WES

    Advanced sequencing that simultaneously analyses a broad range of genes to detect the genetic basis of complex diseases, improve diagnostic accuracy, and inform recurrence risk assessment for better clinical decision-making.

Translating genomic innovation into clinical application

Our research and development teams work with clinical and scientific experts to advance genomic approaches with practical healthcare applications. Through translational research, validation and scientific collaboration, we help move innovation beyond scalable, clinically relevant solutions. Our R&D capabilities are supported by a robust IP portfolio.

Ready to implement genetics
in your clinical or laboratory setting?
Our team of experts
is here to support you

Certified and accredited laboratories

Trusted by healthcare professionals

What I appreciate most about Medicover Genetics is their reliability and precision. The reports are not only accurate but also presented in a way that makes them easily understandable for clinicians across various specialties, which greatly enhances teamwork in patient care. What I appreciate most about Medicover Genetics is their reliability and precision. The reports are not only accurate but also presented in a way that makes them easily understandable for clinicians across various specialties, which greatly enhances teamwork in patient care.

Ileana-Delia Sabau, MD Specialist Medical Genetics, Romania

We are extremely satisfied with the cooperation and service provided by Medicover Genetics. The processes are reliable and the results are impressive in terms of quality.

Natalia Winterholler, Fachärztin für Gynäkologie und Geburtshilfe, Germany

My collaboration with Medicover Genetics has been instrumental in my professional development. It has given me the opportunity to help many patients by providing accurate diagnoses and identifying undiagnosed family members in a timely manner. I’m truly grateful for the positive impact this partnership continues to have on my work.

Stoyan Bichev, Geneticist, National Genetic Laboratory, Bulgaria

Are you a patient?

Latest news

Our global network

As part of the Medicover ecosystem, we connect genetics expertise with healthcare delivery, diagnostics and clinical research, while supporting medical professionals and partners worldwide